|
Advanced search
Previous page
|
Title
Coronavirus disease 2019 diagnostics: key to Africa's recovery |
Full text
http://hdl.handle.net/10451/49937 |
Date
2021 |
Author(s)
Naidoo, Sanushka; Gitaka, Jesse; Suliman, Sara; Baptista, Sara; Oyedemi, Blessing Mbabie; Nepolo, Emmanuel; Enany, Shymaa |
Abstract
© Copyright 2021, Mary Ann Liebert, Inc., publishers - With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa. - SS is supported by an award from the Massachusetts Life Sciences Center Accelerating Coronavirus Testing Solutions (A.C.T.S). JG is funded by the African Academy of Sciences (Grants numbers GCA/MNCH/Round8/207/008 and SARSCov2-4-20-010) and the Royal Society, UK, Grant number FLR\R1\201314. - info:eu-repo/semantics/publishedVersion |
Subject(s)
COVID-19; RT-PCR; SARS-CoV-2; Diagnosis |
Language
eng |
Publisher
Mary Ann Liebert, Inc. |
Relation
https://home.liebertpub.com/publications/dna-and-cell-biology/ |
Type of publication
article |
Rights
openAccess; http://creativecommons.org/licenses/by/4.0/ |
Identifier
DNA Cell Biol. 2021 Oct 12; 1044-5498; 10.1089/dna.2021.0540; 1557-7430 |
Repository
Lissabon - University of Lissabon
|
Added to C-A: 2021-10-21;08:22:15 |
© Connecting-Africa 2004-2024 | Last update: Friday, March 8, 2024 |
Webmaster
|